Email This Article
Headlines & Perspectives
Genentech to Continue Avastin Trial
By
Elizabeth Trotta
10/20/08 - 12:51 PM EDT
The study involves Avastin plus chemotherapy in patients with early-stage colon cancer.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,332.75 | 1,098.23 | 2,182.79 | 35.04 |
Oil *
72.59
|
|
DOWN
108.37
|
DOWN
10.95
|
DOWN
24.12
|
DOWN
0.92
|
10 Yr
3.50%
SPDR Gold
108.32
|
|
-1.04%
|
-0.99%
|
-1.09%
|
-2.56%
|
Data delayed 20 minutes |
Connect with TheStreet